Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general population as being affected (1). NAFLD, while mainly asymptomatic, can progress to non-alcoholic steatohepatitis (NASH) in a portion of individuals. NASH is characterized by multiple pathologic […]
Read MoreMonth: September 2019
Pharma Formulation Services Blog Series Part 3: From Lab to Suite Considerations for Scaling Up
When you finally arrive at a formulation that meets the target product profile, it is then necessary to devise a process by which it can be manufactured at scale. What started as a concept with beakers, stirring rods, and pipettes must become a process with bulk handling and automated or semi-automated equipment. Steps such as sifting, […]
Read MoreNeuroservices-Alliance biggest takeaways and lessons learned from projects and collaborations they’ve experienced throughout the year
So far, 2019 has been the year of building strong relationships between our members and reinforcing our ability to be a one-stop-shop CNS CRO thanks to our complimentary CNS platforms and our strong ensemble of experts. We participated in many of the main Neuroscience events worldwide and still have more to come (BIO Japan, Neuroscience […]
Read MorePharma Formulation Services Blog Series Part 2: Respect the Chemistry
Sometimes you have no choice. “You can have any color you want ‘so long as it is black.’” “Ice cream sold here: vanilla.” You get the idea. So it is with formulation. A substance will demand certain treatment. An API with the solubility of brick dust requires a dosage form to enhance solubility. An API […]
Read More